Skip to search boxSkip to navigationSkip to main content

Establishing Centers of Excellence for Psoriatic Disease in Latin America: Consensus Recommendations From the REAL-PANLAR Group

  • Rodrigo Garcia-Salinas
    ,
  • Alexis Ogdie
    ,
  • Fernando Sommerfleck
    ,
  • Enrique R. Soriano
    ,
  • Andre L. Ribeiro
    ,
  • Verónica Avellanal
*Corresponding author for this work
  • Universidad Nacional de La Plata
    ,
  • Perelman School of Medicine at the University of Pennsylvania
    ,
  • Sanatorio Dr. Julio Méndez
    ,
  • Hospital Italiano de Córdoba
    ,
  • Hospital Moinhos de Vento
    ,
  • Instituto Nacional de Reumatología del Uruguay
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1302-1311 (10 pages)

Journal (Volume, Issue Number)

Journal of Rheumatology (Volume 52, Issue 12)

Publication milestones

  • Published - 01/12/2025

Publication status

Published - 01/12/2025

ISSN

0315-162X

Publication IDs

  • Scopus: 105023544860
  • PubMed: 40816745

Abstract

Objective. Psoriatic disease (PsD) is a chronic, multisystem, inflammatory condition characterized by heterogeneous manifestations, including peripheral arthritis, axial involvement, enthesitis, and cutaneous and nail psoriasis. The condition has significant physical, emotional, and psychosocial effects on patients. In Latin America, healthcare disparities exacerbate delays in diagnosis and treatment, increasing the burden of PsD and associated comorbidities. This study aimed to establish regionally adapted criteria for Centers of Excellence (COEs) to optimize PsD care. Methods. A panel of 18 experts in rheumatology and dermatology from 12 Latin American countries developed COE criteria using the Delphi methodology. A narrative literature review informed the process, and criteria were evaluated using a Likert scale. Consensus was defined as ≥ 70% agreement, and an in-person meeting refined unresolved items. The criteria were categorized into structure, process, and outcomes, based on the Donabedian quality evaluation model. Results. Two types of COEs were defined: optimal and model. Optimal COEs require a multidisciplinary team including rheumatologists, dermatologists, nurses, and psychologists. Model COEs expand this team to include gastroenterologists, ophthalmologists, physiatrists, among other specialists. Structural criteria emphasized infrastructure and electronic systems for data management. Process criteria included patient-centered education, multidisciplinary consultations, and psychosocial support. Outcomes focused on standardized clinimetric tools (eg, Psoriasis Area and Severity Index, Disease Activity Index for Psoriatic Arthritis) and the treat-to-target strategy. Approval ratings ranged from 80% to 100%. Conclusion. The consensus establishes a framework for COEs in PsD care in Latin America, addressing structural, process, and outcome criteria to improve clinical outcomes, patient satisfaction, and healthcare system sustainability. These standards provide a roadmap for enhancing PsD management in resource-limited settings.